戻る Agenda
LS28 Discussion with Patients about Rare Disease Drug Development to Improve Drug Lag in Japan
Session Chair(s)
Harumasa Nakamura, MD, PhD
Director of Department of Clinical Research Support,
National Center of Neurology and Psychiatry, Japan
Speaker(s)
Mihoko Kobayashi
Mihoko Kobayashi
Pfizer R&D Japan, Japan
Japan Development Leader, Clinical Research, Rare Disease
Atsushi Nishizawa
Atsushi Nishizawa
Takeda Pharmaceutical Company Limited, Japan
Head of Plasma-Derived Therapies Strategy Unit
Kosuke Ito, PhD
Kosuke Ito, PhD
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Principal Reviewer